VP
Insider
Versant Ventures VI GP, L.P.
10% ownerVersant Ventures VI GP, L.P. (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in LENZ Therapeutics, Inc. (LENZ). The largest single filing was $10.1M of LENZ (334,801 sh across 3 lots, as filed), executed Jun 18 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$10.1M
shares × price, as filed
Last traded
Jun 20 2025
Filed Jun 20 2025
Median ADV $2.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $10.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
LENZ
LENZ Therapeutics, Inc.
LENZ · 0 buys · 1 sell
1 filing
Recent filings
LENZSALE
LENZ Therapeutics, Inc.
View filing →
$10.1M334,801 sh across 3 lots
Exec Jun 18 2025
Filed Jun 20 2025 · 5:30 PM ET